Stephen J. Kron to Neoplasms
This is a "connection" page, showing publications Stephen J. Kron has written about Neoplasms.
Connection Strength
0.993
-
Small-molecule drug repurposing to target DNA damage repair and response pathways. Semin Cancer Biol. 2021 01; 68:230-241.
Score: 0.253
-
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities. Cancer J. 2019 Mar/Apr; 25(2):106-115.
Score: 0.236
-
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence. Mol Cancer Res. 2016 Feb; 14(2):173-84.
Score: 0.188
-
gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Curr Cancer Drug Targets. 2006 May; 6(3):197-205.
Score: 0.097
-
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. J Natl Cancer Inst. 2021 10 01; 113(10):1285-1298.
Score: 0.071
-
Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotide. J Control Release. 2017 Nov 28; 266:248-255.
Score: 0.054
-
Cellular response to DNA damage. Ann N Y Acad Sci. 2005 Dec; 1066:243-58.
Score: 0.024
-
Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair (Amst). 2004 Aug-Sep; 3(8-9):1245-51.
Score: 0.022
-
Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem. 2004 Jan 16; 279(3):2273-80.
Score: 0.020
-
UltraPlex Hapten-Based Multiplexed Fluorescent Immunohistochemistry. Methods Mol Biol. 2021; 2350:267-287.
Score: 0.017
-
Nanoparticle formulations of cisplatin for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 09; 8(5):776-91.
Score: 0.012